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Abstract
 
We have examined B cell populations that participate in distinct phases of the immune re-
sponse to the influenza virus A/PR/8/34 hemagglutinin (HA) for their susceptibility to nega-
tive selection in mice that express the HA as a neo–self-antigen (HA104 mice). We demon-
strated previously that specificity for the neo–self-HA causes a population of immunoglobulin
G antibody-secreting cells, which dominate the primary response to virus immunization in
BALB/c mice, to be negatively selected in HA104 mice. We find here that in contrast to these
primary response B cells, HA-specific memory response B cells developed equivalently in
HA104 and nontransgenic (BALB/c) mice. Indeed, there was no indication that HA-specific B
cells were negatively selected during memory formation in influenza virus–immunized HA104
mice, even though the neo–self-HA can be recognized by memory B cells. Furthermore, HA-
specific autoantibodies were induced in the absence of virus immunization by mating HA104
mice with mice transgenic for a CD4
 
1
 
 HA-specific T cell receptor. These findings indicate
that specificity for a self-antigen does not prevent the maturation of autoreactive B cells in the
germinal center pathway. Rather, the availability of CD4
 
1
 
 T cell help may play a crucial role
in regulating autoantibody responses to the HA in HA104 mice.
Key words: tolerance • autoantibodies • molecular mimicry • germinal center • CD4
 
1
 
 T cells
 
Introduction
 
After receptor engagement by antigen, B cells can undergo
a variety of differentiative fates. In response to foreign anti-
gens, mature B cells can become activated and differentiate
into antibody-secreting cells (ASCs)
 
1
 
 and/or memory B
cells. These differentiated populations have distinct func-
tional potentials for postactivation events such as antibody
production and somatic hypermutation, and appear to have
developed along different pathways as indicated by their
discrete anatomical locations and their differential expres-
sion of variable region clonotypes (1–3). In some cases, the
pathway along which responding B cells develop can be in-
fluenced by signals mediated via the B cell receptor (BCR
[4]), yet there is also evidence that the preimmune reper-
toire contains separate populations of B cells that are pre-
disposed to certain differentiative fates (5–11). The capacity
for B cell populations to differentiate into either ASCs or
memory B cells may play an important role in providing
effective humoral immunity to complex infectious agents
such as viruses.
In addition to undergoing distinct differentiative fates in
response to foreign antigens, B cells also appear to be heter-
ogeneous in their responses to self-antigens. In recent years,
studies using Ig transgenic (tg) mice have firmly established
that although specificity of the BCR for a self-antigen can
cause self-reactive B cells to be negatively selected from the
primary B cell repertoire (12, 13), this is not absolute, as
some B cells whose BCRs can react with a self-antigen can
persist in the peripheral lymphoid organs of nonautoim-
mune mice (14–16). Moreover, although elimination of
autoreactive B cells from the primary repertoire has been
analyzed in considerable detail, the processes that govern
the fate of autoreactive B cells during memory formation
remain obscure. As it is well established that germinal cen-
ter formation depends on cognate interactions between an-
tigen-specific B cells and CD4
 
1
 
 T cells, negative selection
of autoreactive CD4
 
1
 
 T cells could limit autoreactive
memory B cell formation (17–19). However, self-reactive
B cells activated by a cross-reactive antigen on a microbe
would potentially have a source of linked CD4
 
1
 
 T cell
help (20, 21). Furthermore, B cells responding to foreign
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Abbreviations used in this paper: 
 
AP, alkaline phosphatase; ASC, anti-
body-secreting cell; BCR, B cell receptor; ELISPOT, enzyme-linked im-
munospot; HA, hemagglutinin; HAU, hemagglutinating unit(s); HI, he-
magglutination inhibition; HRP, horseradish peroxidase; PNA, peanut
agglutinin; PR8, influenza virus A/PR/8/34; S1, site 1; tg, transgenic. 
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antigens, through somatic hypermutation, could acquire
reactivity with self-antigens (22–24). Because of these pos-
sibilities, the germinal center has been proposed as a second
window of BCR-mediated tolerance induction (19, 25).
However, there is only indirect evidence that BCR speci-
ficity for self-antigens leads to negative selection of autore-
active B cells during memory formation (26–31). Indeed,
that autoreactive B cells can undergo clonal expansion and
somatic mutation in certain B cell–mediated autoimmune
disorders strongly suggests that autoreactive B cells can ma-
ture through the germinal center pathway (23, 32, 33).
We have been examining how specificity for foreign and
self-antigens affects B cell differentiation by using the influ-
enza virus A/PR/8/34 (PR8) hemagglutinin (HA) as a
well-characterized antigen (34, 35). We demonstrated pre-
viously that HA-specific B cells induced in response to
PR8 virus immunization in BALB/c mice are composed of
distinct populations that respond differently to antigenic
stimulation by the HA. A major population of IgG-secret-
ing ASCs dominates the primary response 5 d after immu-
nization, and includes B cells that use a BCR clonotype
(termed C12) that utilizes characteristic H chain variable
(VH) and 
 
k
 
 chain variable (Vk) gene segments (5, 36). Sev-
eral lines of evidence indicate that C12 B cells predomi-
nantly undergo terminal differentiation into IgG ASCs in
response to virus immunization and that they do not partic-
ipate in germinal center reactions in BALB/c mice (37).
However, other clonotypes (including a clonotype termed
C4) have been identified that are typically isolated among
IgM-secreting hybridomas 5 d after immunization, and as
somatically mutated and IgG-secreting hybridomas after
secondary challenge (38). Further evidence of the distinct
phenotypic potentials exhibited by these two populations
of HA-specific B cells emerged with the observation that
C12 B cells are negatively selected in tg mice that express
the HA as a neo–self-antigen (HA104 mice), whereas HA-
specific IgM-secreting B cells (including C4 B cells) were
readily isolated after primary immunization (5). The find-
ing that C4 B cells evaded negative selection from the pri-
mary B cell repertoire in HA104 mice despite their speci-
ficity for the neo–self-HA provided an opportunity to
examine the extent to which mechanisms exist to mediate
their negative selection during memory formation. We
show here that HA104 and non-tg(BALB/c) mice generate
equivalent HA-specific B cell responses after secondary im-
munization, and that HA-specific C4 B cells can undergo
somatic hypermutation and clonal expansion in HA104
mice. In addition, we examine the role that CD4
 
1
 
 T cell
help plays in the generation of autoantibody responses to
the neo–self-HA.
 
Materials and Methods
 
Mice.
 
HA104 and site 1 (S1)-specific TCR transgene (TS1)
mice were described previously (5, 39–41). Both lineages were
backcrossed to BALB/c mice (Harlan) at least 7 and in most cases
 
.
 
10 generations before use in these experiments and were main-
tained in sterile microisolators at The Wistar Institute Animal Fa-
 
cility. In multiple experiments, non-tg littermates of HA104 mice
generated equivalent ASC responses to BALB/c mice after virus
immunization. Therefore, both non-tg and BALB/c mice were
used in these experiments and are referred to as non-tg(BALB/c)
mice.
 
Viruses and Immunizations.
 
Influenza viruses PR8 (A/Puerto
Rico/8/34 [H1N1]), T3 (a mutant PR8 virus containing an as-
partic acid to glycine interchange at amino acid 227 [35, 42]), and
J1 (a reassortant of PR8 containing the nonserologically cross-
reactive H3 HA [H3N1]; references 43, 44) were grown in the
allantoic cavity of 10-d-old fertilized chicken eggs, purified by
sucrose gradient centrifugation, and titered by chicken RBC ag-
glutination (45). Mice were primed for memory B cell responses
by immunization with 1,000 hemagglutinating units (HAU) in-
traperitoneally purified T3 or PR8 virus. For primary and sec-
ondary responses, mice were killed 5 or 3 d, respectively, after
immunization with 1,000 HAU T3 or PR8 virus intravenously
in 0.2 ml PBS. Secondary immunizations were performed a min-
imum of 4 wk after primary immunization.
 
Virus-specific ELISA.
 
ELISAs were done using purified T3,
PR8, and J1 viruses as immunadsorbents as described previously
(5). In brief, polyvinyl 96-well plates were coated with 25 
 
m
 
l di-
luted virus (1,000 HAU/ml in PBS plus azide). After incubation
overnight at 4
 
8
 
C, plates were blocked with 1% BSA in PBS plus
azide. Hybridoma culture supernatants or serum were added (di-
luted in 1% BSA in PBS plus azide) for 90 min. Bound antibody
was detected by using alkaline phosphatase (AP)-conjugated goat
anti–mouse IgG and/or IgM (diluted 1:1,000 in PBS plus azide;
Southern Biotechnology Associates, Inc.) and developed using
 
p
 
-nitrophenyl phosphate. Absorbances were read at 405 nm using
a microplate reader.
 
Hemagglutination Inhibition Assay.
 
The ability of antibodies to
neutralize viral agglutination of chicken RBCs was measured as
described previously (45). In brief, 4 HAU of PR8 virus were
plated (25 
 
m
 
l) in 96-well Multiscreen-HA plates (Millipore).
Twofold dilutions of serum beginning with 1:100 were added
(25 
 
m
 
l) to the virus and incubated for 1 h. 50 
 
m
 
l 1% RBCs was
added and incubated for 30 min. Hemagglutination inhibition
(HI) titers were determined as the highest serum dilution capable
of inhibiting hemagglutination.
 
Enzyme-linked Immunospots.
 
Virus-specific enzyme-linked im-
munospots (ELISPOTs) were done using purified T3, PR8, and
J1 as described previously (5). In brief, 96-well Multiscreen-HA
plates (Millipore) were coated with 50 
 
m
 
l diluted virus (1,000
HAU/ml in PBS). After overnight incubation (4
 
8
 
C), plates were
blocked with 0.2 ml supplemented IMDM plus 5% FCS (40).
Splenocytes were plated in triplicate in 0.2 ml at 1 
 
3 
 
10
 
6
 
, 2.5 
 
3
 
10
 
6
 
, 6.25 
 
3
 
 10
 
5
 
, and 1.25 
 
3
 
 10
 
5
 
 cells/well for 4 h at 37
 
8
 
C.
Bound antibody was detected with AP goat anti–mouse IgG
and/or IgM (Southern Biotechnology Associates, Inc.). AP was
developed with nitro blue tetrazolium and 5-bromo-4-chloro-3-
indolyl phosphate in 0.1 M NaHCO
 
3 
 
plus 0.001 M MgCl
 
2
 
. ASC
spots were counted using a dissecting scope.
 
Immunohistochemistry.
 
Spleens were submerged in OCT
(VWR Scientific), frozen with 2-methyl butane cooled with dry
ice, sectioned, and fixed with acetone. Sections were stained as
described (2). In brief, sections were blocked using PBS/2%
BSA/0.1% Tween 20 and then stained with anti-IgD–biotin
(Southern Biotechnology Associates, Inc.), peanut agglutinin
(PNA)–horseradish peroxidase (HRP; EY Labs), and Extravidin-
AP (Sigma-Aldrich) diluted in PBS/2% BSA/0.1% Tween 20.
AP and HRP were developed using Fast-Blue BB base and
3-amino-9-ethyl carbazole (Sigma-Aldrich), respectively. 
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Hybridoma Generation.
 
Hybridomas were generated from T3-
immunized mice 3 d after secondary immunization by fusion
with Sp2/0-Ag14 cells and subsequent selection with hypoaxan-
thine–azaserine as described previously (5). 10 d after fusion, hy-
bridoma supernatants were aspirated and replaced with IMDM
plus 10% FCS. Supernatants were screened 2 d later by ELISA for
reactivity against T3 virus. T3-reactive hybridomas were ex-
panded and their supernatants were screened for reactivity with
T3, PR8, and J1 viruses and for H chain isotype.
 
Sequence Analysis of Antibody V Regions.
 
Sequence analysis of
hybridoma Ig H and L chain mRNA V regions was performed as
described previously (5). In brief, RNA was isolated from 
 
z
 
10
 
6
 
hybridoma cells and reverse transcribed using a 
 
k 
 
L chain and ap-
propriate H chain C region–specific primer under standard con-
ditions (46). PCR was carried out on the resulting cDNA using
appropriate C chain and V region–specific primers: VH5
 
9
 
1 or
VH5
 
9
 
2 to amplify H chain V regions and VkC4 to amplify L
chains (5, 47). Amplified products were run on a 1% agarose gel
and purified using GeneCleanII (Bio101). Sequences were ob-
tained using four-color dye chemistries with the ABI 373S se-
quencer (PerkinElmer) at the Nucleic Acid Facility at The Wistar
Institute.
 
Flow Cytometry.
 
Flow cytometric analysis was performed on
single cell suspensions made from pooled inguinal, brachial, axil-
lary, and superficial cervical LNs on a FACScan™ flow cytome-
ter (Becton Dickinson). 400,000–500,000 events were collected
and analyzed using CELLQuest™ (Becton Dickinson). Antibod-
ies used for staining were anti-CD4–FITC (GK1.5; BD Phar-
Mingen), anti-CD69–PE (BD PharMingen), and 6.5-biotin (41)
detected by Streptavidin 670 (GIBCO BRL). 
 
Results
 
HA104 and Non-tg(BALB/c) Mice Generate Equivalent
HA-specific ASC Responses after Secondary Immunization.
 
HA104 mice express the influenza virus PR8 HA as a
membrane-bound neo–self-antigen in a wide variety of tis-
sues, including the bone marrow, spleen, and thymus (5,
39). To examine how the neo–self-HA affects the ability of
HA104 mice to generate HA-specific B cell responses,
HA104 and non-tg(BALB/c) mice were immunized with
the virus T3 (a virus identical to PR8 except for a single
amino acid difference in a B cell epitope of HA [35, 42]).
Using whole virus as an immunogen ensured that T cell
help would not be limiting for HA-specific B cells, as T
cells directed to other proteins in the virus particle could
provide a source of intermolecular cognate help for HA-
specific B cells (20, 48). Additionally, using T3 rather than
PR8 virus to challenge the mice permitted an analysis of
the fine specificity of the anti-HA antibody response (see
below). 5 d after primary, or 3 d after secondary immuniza-
tion, splenocytes from immunized animals were analyzed
for the frequency of ASCs by ELISPOT (Fig. 1). We ini-
tially determined the frequency of ASCs that could react
with the HA by comparing the frequencies that could react
with PR8 virus with those that could react with the reas-
sortant virus J1. J1 is identical to PR8 except for the pres-
ence of a serologically non–cross-reactive HA, and quanti-
tates the frequency of ASCs that are directed to non-HA
viral components (i.e., other virus proteins and compo-
 
nents such as carbohydrates that derive from propagating
the virus in hen eggs [43, 44]). The excess frequency of
PR8-specific ASCs over J1-specific ASCs therefore indi-
cates the number of HA-specific ASCs that were induced
in response to virus immunization.
As described previously, splenocytes from non-tg(BALB/
c) mice contained a sizable population of HA-specific IgG
ASCs 5 d after primary immunization (5, 36; Fig. 1 A). The
frequency of HA-specific IgG ASCs induced in HA104
mice was substantially lower than in non-tg(BALB/c) mice,
recapitulating our previous demonstration that HA-specific
primary response IgG ASCs are negatively selected in
HA104 mice because of their specificity for the neo–self-
HA (Fig. 1 A). As we also observed previously, HA-specific
IgM ASCs were induced with similar frequencies in non-
tg(BALB/c) and HA104 mice 5 d after primary T3 immu-
nization (Fig. 1 A). When splenocytes from non-tg(BALB/
c) and HA104 mice were examined 3 d after secondary im-
munization, equivalent frequencies of HA-specific IgG
ASCs were detected (Fig. 1 B). The frequencies of HA-spe-
cific IgG ASCs induced in both strains of mice were
roughly threefold higher than were induced in non-
tg(BALB/c) mice after primary virus immunization, consis-
tent with the activation of memory response B cells. Thus,
in contrast to the primary response (Fig. 1 A), HA-specific
IgG ASCs were as abundant after secondary immunization
of HA104 mice as they were in non-tg(BALB/c) mice.
To examine the magnitude of the HA-specific memory
B cell response at the level of serum antibody, we measured
the ability of serum antibodies obtained after secondary vi-
rus immunization of HA104 and non-tg(BALB/c) mice to
inhibit hemagglutination (HI assay). The ability of antibod-
ies to neutralize virus-induced hemagglutination in vitro
requires B cell recognition of conformation-dependent
epitopes on the HA and correlates with the ability of anti-
bodies to protect against viral infection (49, 50). As shown
in Fig. 1 E, the HI titers of serum from HA104 and non-
tg(BALB/c) mice after secondary virus immunization were
equivalent. Together, the findings indicate that secondary
virus immunization induces memory B cell responses in
HA104 and non-tg(BALB/c) mice that are of equivalent
magnitude and that in each case are directed towards con-
formation-dependent epitopes on the HA molecule.
 
HA104 and Non-tg(BALB/c) Mice Do Not Differ in the
Fine Specificity of Their Memory B Cell Response to T3 Vi-
rus.
 
As similar frequencies of HA-specific IgG ASCs
could be activated from the memory B cell pool after a sec-
ond exposure to virus in HA104 and non-tg(BALB/c)
mice, this implied that HA-specific B cells are not nega-
tively selected during memory B cell formation in HA104
mice. However, because B cell memory formation involves
a series of poorly understood selection events that allow
rare somatic mutants to preferentially expand and ulti-
mately populate the memory pool (51, 52), we wanted to
examine more closely whether HA-specific B cells are
counterselected during the generation of the memory B
cell pool. To this end, we examined the fine specificity of
the response to T3 virus. The frequency of HA-specific B 
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cells was related to those directed either to a non–self-
epitope on the HA (the T3 mutation) or to other non-HA
viral components (indicated by reactivity with J1). In this
way, the frequency of B cells directed to T3 and J1, which
provide a measure of those memory B cells specific for for-
eign (non-self) epitopes on the immunizing antigen, could
be compared with the frequency with which anti–self-HA–
specific B cells were generated in HA104 mice.
When the specificity of the primary response (Fig. 1 C)
to T3 virus was examined in non-tg(BALB/c) mice, the
majority of the ASCs were HA specific (i.e., did not react
with J1 virus). A small excess of ASCs that could react with
T3 but not with PR8 virus could also be detected, and cor-
responded to ASCs that recognize the mutant T3 epitope
on the HA. In HA104 mice, the magnitude and the speci-
ficity of the primary IgM ASC response closely paralleled
that of non-tg(BALB/c) mice. However, as described
above, the frequency of IgG ASCs that could react with
PR8 virus was decreased roughly fivefold relative to non-
tg(BALB/c) mice. Moreover, because HA-specific IgG
ASCs were negatively selected in HA104 mice, the relative
proportion of the total IgG ASCs that were specific for
the non–self-T3 epitope more than doubled in HA104
mice compared with non-tg(BALB/c) mice (64 vs. 27%).
Therefore, at the level of the primary response, negative se-
lection of HA-specific B cells altered the fine specificity of
the IgG ASC response, which became skewed toward re-
activity with the T3 mutation.
Figure 1. Specificity of ASC for-
mation in T3-immunized non-
tg(BALB/c) and HA104 mice. Mice
were analyzed 5 d after primary im-
munization (n 5 4 mice/group; A
and C) or 3 d after secondary immu-
nization (n  5 6 non-tg(BALB/c)
and  n 5 4 HA104 mice; B and D)
for T3 (T)-, PR8 (P)-, and J1 (J)-
specific ASCs by ELISPOT or HI
titers (E). The magnitude of HA-
specific component (A and B) was
derived from subtracting the mean
frequencies of ASCs measured on J1
virus from those measured on PR8
virus. Fine specificity (C and D) in-
dicates absolute ASC values obtained
using T3 virus (T), PR8 virus (P),
and J1 virus (J). Filled circles and
black bars, IgM ASCs; open circles
and white bars, IgG ASCs. Symbols
represent individual mice and bars
indicate the mean frequencies in
each set. (E) HI titers in naive versus
immunized non-tg(BALB/c) and
HA104 mice 3 d after secondary im-
munization. 
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After secondary immunization (Fig. 1 D), the frequen-
cies of IgM and IgG ASCs that could react with T3 virus
increased substantially relative to the primary response, and
were of equivalent magnitudes in HA104 and non-
tg(BALB/c) mice. The IgM ASCs from HA104 and non-
tg(BALB/c) mice reacted equally well with T3, PR8, and
J1 viruses, indicating that these secondary response IgM
ASCs were almost exclusively specific for non-HA epitopes
on the virus particle. Non-HA epitopes include other viral
epitopes as well as components that derive from propagat-
ing influenza virus in hen eggs, and it is possible that these
secondary response IgM ASCs are directed to egg-derived
carbohydrate molecules. Strikingly, the frequencies of T3-,
PR8-, and J1-specific IgG ASCs were also similar in
HA104 and non-tg(BALB/c) mice, and in each case
roughly half of the IgG ASCs could react with T3 and PR8
but not with J1 and were therefore HA specific. Thus, un-
like the primary response in which the IgG ASC responses
in HA104 mice were predominantly directed toward the
non–self-T3 epitope, memory B cell responses in HA104
mice were not skewed toward either the T3 mutation or
non-HA epitopes on the virus particle.
To examine the specificity of the antibody response to
T3 virus at the level of individual B cells, B cell hybridomas
were generated 3 d after secondary immunization of
HA104 and non-tg(BALB/c) mice and analyzed for their
ability to react with T3, PR8, and J1 viruses (Table I).
Consistent with the ELISPOT data, the overwhelming
majority of the IgM-secreting hybridomas isolated from ei-
ther HA104 or non-tg(BALB/c) mice were specific for
non-HA viral components. The IgG-secreting hybridomas
also closely paralleled the ELISPOT analysis, in that both
the absolute numbers of HA-specific hybridomas isolated
from HA104 and non-tg(BALB/c) mice, and the relative
numbers of HA-, T3-, and J1-specific hybridomas were
similar. Thus, based on the specificity of the B cell response
to T3 virus, HA-specific B cells do not appear to be nega-
tively selected during memory B cell formation in HA104
mice. Indeed, anti–self-HA–specific B cells did not appear
to be at any disadvantage relative to either T3-specific, or
to non-HA antiviral B cells in their ability to enter and be
reactivated from the memory B cell pool.
 
HA-specific B Cells Undergo Clonal Expansion and Somatic
Mutation in HA104 Mice.
 
To examine the extent to
which HA-specific secondary response B cells in HA104
mice had undergone somatic mutation and clonal expan-
sion, HA-specific hybridomas generated from HA104 mice
after secondary T3 immunization were analyzed for the se-
quences of their Ig V regions. We focused this analysis to-
ward identifying hybridomas that utilize a B cell clonotype
(designated C4) that is characterized by the use of a Vk
gene segment (VkC4) from the Vk8 gene family in con-
junction with the Jk5 gene segment. B cells that use the C4
clonotype have been shown previously to participate in
memory responses to the HA in non-tg(BALB/c) mice
(38). Moreover, in our previous studies we showed that C4
B cells were frequently represented among IgM-secreting
HA-specific B cell hybridomas that were isolated 5 d after
 
primary T3 immunization from HA104 mice (5). Accord-
ingly, a panel of PR8 HA–specific hybridomas that had
been isolated from HA104 mice were initially screened by
reverse transcription PCR to determine whether they used
L chain genes from the Vk8 gene family (53). 34 of 90 PR8
HA–specific hybridomas examined from HA104 mice were
found to express L chains from the Vk8 gene family, and
these hybridomas were selected for more detailed analysis of
their H and L chain gene sequences. Of the 34 hybridomas
that had initially been found to use a Vk8 gene family
member, 19 were found upon sequence analysis to use the
C4 clonotype (i.e., used the VkC4 gene segment joined to
Jk5). Vk8
 
1
 
 hybridomas were also analyzed for their H
chain rearrangements. Hybridomas that utilize the C4
clonotype were found to use members of several different
VH gene families, consistent with the previous character-
ization of C4 B cell hybridomas isolated from non-
tg(BALB/c) mice (38). Among the C4
 
1
 
 hybridomas iso-
lated from one of the HA104 mice was a group of six (one
IgM and five IgG3 secretors) that had identical CDR3
junctional sequences despite having other individual differ-
ences (Fig. 2 A). Their shared H chain junctional sequences
indicate that these hybridomas had derived from the clonal
 
Table I.
 
Specificity Analysis of Secondary Response Hybridomas
 
Non-tg
(BALB/c) HA104
Donor IgM IgG IgM IgG
HA-specific
 
*
 
10 7 2 1 7
2 4 10 3 15
3 0 17 2 10
Total
 
43 4 7 4 2
 
Fine specificity
T3 epitope
 
‡
 
10 2 1 5
20 1 2 0
30 0 0 2
Total
 
03 3 7
 
Viral, non-HA
 
§
 
12 1 2 9 3 9 4 0
2 18 8 39 12
33 9 2 3 2 5 1 7
Total
 
78 60 103 69
 
Specificity analysis of B cell hybridomas isolated after secondary T3
immunization of HA104 mice. Hybridomas from HA104 and non-
tg(BALB/c) mice were generated 3 d after secondary immunization
with T3 virus. Hybridoma supernatants were analyzed for reactivity
with T3, PR8, and J1 viruses and for H chain isotype usage.
 
*
 
Number and H chain isotype of hybridomas that react with PR8 but
not J1 virus (in most cases binding to J1 virus was undetectable and at
least 100-fold lower than to PR8 virus).
 
‡
 
Number and H chain isotype of hybridomas that react only with T3
(
 
.
 
10-fold higher binding to T3 virus than to PR8 virus; binding to
PR8 and J1 was usually undetectable).
 
§
 
Number and H chain isotype of hybridomas that react equally with
T3, PR8, and J1. 
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progeny of a single B cell, and therefore the individual dif-
ferences between these hybridomas are almost certainly the
result of somatic hypermutation that occurred during clonal
expansion of these HA-specific B cells in vivo (24). A sec-
ond group of clonally related HA-specific B cells was iso-
lated from a different HA104 mouse (Fig. 2 B). In this case,
a pair of IgG2a-secreting hybridomas was identified that use
L chains encoded by a Vk8 gene segment other than VkC4
in conjunction with closely related H chain gene se-
quences. Again, these hybridomas displayed identical H
chain junctional sequences and individual nucleotide differ-
ences that are likely the result of somatic hypermutation. As
clonal expansion and somatic hypermutation occur pre-
dominantly in germinal centers (51, 54), these findings pro-
vide strong evidence that these HA-specific memory B cells
had developed in the germinal centers of HA104 mice.
 
The Neo–self-HA Can Stimulate HA-specific Autoantibody
Production in the Absence of Virus Immunization.
 
As germi-
nal center reactions and memory B cell formation appear to
be strictly dependent on CD4
 
1 
 
T cell help (17, 55, 56), it is
likely that CD4
 
1
 
 T cells directed toward non-HA viral
proteins provided a source of intermolecular cognate help
for HA-specific memory B cells in T3-immunized HA104
mice. To examine whether the provision of HA-specific
CD4
 
1
 
 T cells might allow autoantibody production in the
absence of virus immunization, we examined whether HA-
specific serum antibody could be detected in HA104 mice
that had been mated with HA-specific TCR tg mice (TS1).
TS1 mice express a tg TCR that is specific for the major
I-Ed–restricted T cell determinant from the HA (designated
S1 [57]). In TS1 mice, 
 
z
 
30% of the peripheral CD4
 
1
 
 T
cells express high levels of the clonotypic TCR as detected
with the anticlonotypic monoclonal antibody 6.5 (41). In
TS1 
 
3
 
 HA104 mice, the majority of the clonotypic T cells
 
are deleted during their development in the thymus (58).
Nonetheless, a higher number of peripheral LN cells in
TS1 
 
3
 
 HA104 mice were detected by the 6.5 monoclonal
antibody than were detected in non-tg(BALB/c) mice
(1.1
 
 6 
 
0.6 
 
3
 
 10
 
6
 
 vs. 0.5
 
 6 
 
0.4 
 
3
 
 10
 
6
 
), indicating that some
HA-specific CD4
 
1
 
 T cells evade deletion in TS1 
 
3
 
HA104 mice (Fig. 3 A). This conclusion is supported by
recent studies in which we demonstrated that CD4
 
1
 
 T cells
that evade deletion in TS1 
 
3
 
 HA104 mice could be acti-
vated by S1 peptide in vitro and by PR8 virus in vivo (58).
To examine whether the T cells that evade deletion in TS1 
 
3
 
HA104 mice might have interacted with the S1 peptide
in vivo, freshly isolated LN cells from non-tg(BALB/c),
TS1, and TS1 
 
3
 
 HA104 mice were stained with anti-
CD4, 6.5, and anti-CD69 antibodies and analyzed by flow
cytometry (Fig. 3 B). In the LN cells from TS1 mice, the
percentage of 6.5
 
1
 
 cells that were CD69
 
1
 
 was similar to
the percentage of total 6.5
 
lo 
 
cells that were CD69
 
1
 
 (7.6 vs.
7.8%). By contrast, the 6.5
 
1
 
 cells in TS1 
 
3
 
 HA104 mice
contained higher percentages of CD69
 
1
 
 cells than were
found on 6.5
 
lo
 
 cells (24.3 vs. 8.1%). As increased levels of
CD69 are characteristic of antigen-experienced T cells (59,
60), the higher levels present on the autoreactive 6.5
 
1
 
 T
cells suggest that these T cells had interacted with the S1
peptide in vivo.
To examine whether T cells that evade deletion in TS1 
 
3
 
HA104 mice are capable of providing help for autoanti-
body responses to the HA in vivo, we examined unimmu-
nized non-tg(BALB/c), HA104, TS1, and TS1 
 
3
 
 HA104
mice for their levels of PR8 HA–specific serum antibody in
an ELISA (Fig. 4). HA-specific serum antibody levels were
below the limit of detection in non-tg(BALB/c), HA104,
and TS1 mice. By contrast, TS1 
 
3
 
 HA104 mice contained
significant titers of anti-HA antibodies; indeed, the HA-
Figure 2. VH and Vk se-
quence analysis identifies two
sets of clonally related and so-
matically mutated HA-specific
hybridomas from HA104 mice.
VH and Vk sequences of hy-
bridomas derived from mouse
7973 (A) and 7002 (B) are ar-
ranged relative to an individual
hybridoma from each set, and
the relative locations of individ-
ual nucleotide differences are in-
dicated by lowercase letters. The
locations of CDRs are indicated
by brackets (reference 70). The
sequence for the H chain CDR3
nucleotide region is shown in
uppercase letters. Hybridoma
7973-301 is an IgM secretor, and
the remaining hybridomas from
mouse 7973 are IgG3 secretors.
Both 7002-1116 and 7002-1439
are IgG2a secretors. Sequence
data are available from EMBL/
GenBank/DDBJ under accession
nos. AF265682–AF265687. 
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specific antibody titers of TS1 
 
3
 
 HA104 mice exceeded
those that were present in non-tg(BALB/c) mice 5 d after
primary PR8 virus immunization, and were equivalent to
the antiviral titers present after secondary virus immuniza-
tion of non-tg(BALB/c) mice. In addition, whereas the
sera from virus-immunized non-tg(BALB/c) mice con-
tained antibodies that could react with both PR8 and J1 vi-
rus (and were therefore directed toward both the HA and
to non-HA viral components), those from TS1 
 
3
 
 HA104
mice displayed no detectable reactivity with J1 virus. The
lack of reactivity with J1 virus in TS1 
 
3
 
 HA104 mice is
consistent with the activation of HA-specific B cells by the
neo–self-HA (as opposed to viral particles). To determine
whether the HA-specific antibodies elicited in naive
TS1 
 
3
 
 HA104 mice were directed against conformational
epitopes on the HA molecule that are shared between the
neo–self-HA and the virally expressed HA, sera from
TS1 
 
3
 
 HA104 mice were examined for their ability to in-
hibit viral hemagglutination. As indicated in Fig. 4 B, se-
rum from unimmunized TS1 3 HA104 mice exhibited HI
titers that were comparable to those of virus-immunized
non-tg(BALB/c) mice (Fig. 4 E). As signals mediated via
the BCR are necessary for B cell differentiation into anti-
gen-specific ASCs (61), the presence of high titers of con-
formation-dependent PR8 HA–specific serum antibody in
TS1 3 HA104 mice provides strong evidence that the
neo–self-HA is recognized by autoreactive HA-specific B
cells in HA104 mice. Moreover, because HA-specific anti-
body was detected in TS1 3 HA104 but not in HA104
mice, the generation of these HA-specific antibodies ap-
peared to depend on HA-specific CD41 T cell help that
was provided by the rare 6.51 T cells that evaded deletion
by the HA.
The Neo–self-PR8 HA in HA104 Mice Can Be Recognized
by HA-specific Memory B Cells. Although the preceding
studies indicated that the HA can be recognized as B cell
autoantigen in HA104 mice, we wanted to examine di-
rectly whether the HA can be recognized by memory B
Figure 3. 6.51CD41 LN cells that evade deletion in TS1 3 HA104
show evidence of in vivo activation. LN cells from naive TS1, TS1 3
HA104, and non-tg(BALB/c) mice were harvested and stained with anti-
CD4, 6.5, and anti-CD69 for analysis by three-color flow cytometry. (A)
Histogram of 6.5 staining on CD41 LN cells from TS1, TS1 3 HA104,
and non-tg(BALB/c) mice. Gates marking 6.5lo and 6.51 cells are indi-
cated. The average numbers (based on multiple mice) of 6.51CD41 LN
cells (3 1026 6 SD) from the three lineages are as follows: TS1 mice
(15.3 6 8.4, n 5 14), TS1 3 HA104 mice (1.1 6 0.6, n 5 11), and non-
tg(BALB/c) mice (0.5 6 0.4, n 5 7). (B) Histograms of CD69 expression
on 6.5lo and 6.51 CD41 LN cells from TS1 and TS1 3 HA104 mice.
The percentage of gated cells staining positive for CD69 is indicated.
Scales for the CD69 histograms have been adjusted to account for differ-
ences in the number of 6.5lo and 6.51 cells. Data are representative of at
least three experiments.
Figure 4. TS1 3 HA104 mice contain high titers of HA-specific se-
rum antibody. Serum from unimmunized HA104, TS1, and TS1 3
HA104 mice, as well as serum from non-tg(BALB/c) mice collected ei-
ther 5 d after primary (18) or 3 d after secondary immunization with PR8
virus (28), was assayed for reactivity with PR8 and J1 viruses in an ELISA
(A) or for their ability to inhibit hemagglutination (B). (A) Data are ex-
pressed as the reciprocal of the dilution necessary to yield an absorbance at
405 nm (Abs405) of 0.35. Filled circles, PR8-specific titers; open circles,
J1-specific titers from individual mice; bars, mean titers for each set of
mice. (B) Data are expressed as the reciprocal of the dilution necessary to
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cells. Accordingly, non-tg(BALB/c) mice were immunized
with PR8 virus, and after 6 wk their splenocytes were de-
pleted of T cells and then transferred into naive HA104 or
non-tg(BALB/c) mice with or without the addition of LN
cells from TS1 mice as a source of HA-specific CD41 T
cells (Fig. 5). 5 d after transfer, the spleens of recipient mice
were assayed for the presence of ASCs by ELISPOT and by
immunohistochemistry for histologic signs of B cell activa-
tion (e.g., germinal center formation). In non-tg(BALB/c)
mice that received both primed B cells and TS1 T cells,
there was little or no B cell activation as evidenced either
by ASC formation or by histologic examination (Fig. 5).
The few ASCs that were detected by ELISPOT in non-
tg(BALB/c) mice were primarily specific for non-HA viral
components, and presumably include ASCs reacting to re-
sidual antigen that was transferred with the splenocytes. In
HA104 mice that received primed B cells but no TS1 T
cells, the frequency of ASCs directed to nonviral compo-
nents was the same as in non-tg(BALB/c) mice, but the fre-
quency of HA-specific ASCs (i.e., those that could react
with PR8 but not with J1) now exceeded by roughly two-
fold those directed to non-HA viral components. When
both primed B cells and TS1 T cells were transferred into
HA104 mice, HA-specific ASCs were roughly 10-fold
more abundant than those directed to non-HA viral com-
ponents. The spleens of HA104 mice that received both
primed B cells and TS1 T cells also contained abundant,
well-organized germinal centers that displayed characteristic
staining with PNA. HA104 mice that received T cells alone
did not mount a detectable HA-specific ASC response (Fig.
5), and the spleens of these recipients did not show evi-
dence of germinal center formation (data not shown), indi-
cating that the HA-specific B cell response was due to the
activation of transferred memory B cells. Therefore, the
neo–self-HA is expressed in HA104 mice in a form and lo-
cation recognized by HA-specific memory B cells, and in
the presence of HA-specific T cell help, induces both ger-
minal center and HA-specific ASC formation.
Discussion
We have examined tg mice that express the influenza vi-
rus HA as a membrane-bound neo–self-antigen (HA104
mice) for their ability to generate HA-specific B cell re-
sponses after primary and secondary virus immunization.
We found that a population of IgG-secreting ASCs that
dominates the day 5 primary response to HA in virus-
immunized BALB/c mice is negatively selected from the
primary B cell repertoire in HA104 mice. By contrast, a pop-
ulation of HA-specific B cells that evades negative selection
from the primary B cell repertoire gave rise to memory B
cell responses in virus-immunized HA104 mice that were
of equal magnitude to those induced in non-tg(BALB/c)
mice. Inasmuch as the HA-specific autoreactive B cells
were somatically mutated and clonally expanded, these
studies provide evidence that specificity for a self-antigen
does not prevent the maturation of autoreactive B cells in
the germinal center pathway. Indeed, if provided with
CD41 T cell help, autoreactive HA-specific B cells ap-
peared to be selected into and reactivated from the mem-
ory B cell pool as efficiently as B cells directed to non–self-
epitopes on an immunizing influenza virus.
Figure 5. HA-specific memory B cell activation by transgene-encoded
HA in HA104 mice. (A) The frequency of ASCs in splenocytes was de-
termined by ELISPOT in either non-tg(BALB/c) or HA104 mice 5 d af-
ter receiving T cell–depleted splenocytes (termed B cells [B]) from non-
tg(BALB/c) mice primed 6 wk earlier with PR8 virus either alone (a
source of virus-primed B cells) or in conjunction with LN cells from TS1
mice (termed T cells plus B cells [T 1 B]). Additionally, one group of
mice received only LN cells from TS1 mice (T cells [T]). Bars indicate
the mean frequency of ASCs that react with PR8 virus (gray bars) and J1
virus (white), 6 SEM (n 5 3–4 mice per group). (B and C) Immunohis-
tochemical analysis of spleen sections of HA104 (B) or non-tg(BALB/c)
(C) recipients of T cell–depleted splenocytes from non-tg(BALB/c) mice
and TS1 LN cells. Spleen sections were stained with anti-IgD–biotin, avi-
din-AP, and PNA-HRP. HRP and AP were developed using the sub-
strates 3-amino-9-ethyl carbazole (red) and Fast-Blue BB base (blue), re-
spectively. Staining is representative of at least three separate experiments.
Original magnifications: 3100.1771 Reed et al.
Although processes governing the negative selection of
autoreactive B cells from the primary B cell repertoire have
been extensively studied, how and if autoreactive B cells
that evade negative selection from the primary B cell reper-
toire (or that acquire autoreactivity via somatic mutation)
are regulated during memory formation has received little
analysis. Because we found previously that separate popula-
tions of HA-specific B cells differed in their susceptibility
to negative selection from the primary B cell repertoire in
HA104 mice, we were able to evaluate whether a second
window of tolerance induction might lead to the elimina-
tion of HA-specific B cells during memory B cell forma-
tion. We found that HA104 and non-tg(BALB/c) mice
generated HA-specific memory B cell responses that were
of equivalent magnitude. Moreover, the relative frequen-
cies of memory B cells directed to the HA versus those di-
rected either to a mutated epitope on the HA (the T3 mu-
tation) or to non-HA epitopes on the virus (e.g., the
nucleoprotein) were equivalent in HA104 and non-tg
mice. Previous studies of antibody responses to species
variants of self-proteins such as cytochrome c, hemoglobin,
and MHC class II have demonstrated that negative selec-
tion of autoreactive B cells can focus the antibody re-
sponses toward epitopes that differ from the self-protein
(62–64). However, in these previous studies, the extent to
which focusing of the response to non–self-epitopes re-
flected negative selection of autoreactive B cells from the
primary repertoire versus during formation of the memory
B cell pool was not established. We found that whereas
negative selection of HA-specific B cells skewed the T3-
induced primary response IgG ASCs toward specificity for
the non–self-T3 mutation, this was not true for the mem-
ory response in HA104 mice. Thus, even though memory
B cells are produced through stochastic processes that re-
quire the generation, selection, and expansion of mutated
B cells (11, 51, 52, 54), we did not find any evidence that
HA-specific B cells in HA104 mice were at a disadvantage
relative to B cells directed to epitopes other than HA on
the same immunizing virus particle.
Why are HA-specific B cells not negatively selected dur-
ing memory formation in HA104 mice? Antigen sequestra-
tion has been proposed as a reason that autoreactive B cells
can avoid regulation by (or be “ignorant” of) self-antigens
(65). However, three lines of evidence suggest that the HA
is accessible to and can be recognized by HA-specific B
cells in HA104 mice. First, the neo–self-HA is responsible
for the negative selection of a major subset of HA-specific
B cells from the primary B cell repertoire. Second, the
neo–self-HA was able to activate HA-specific memory B
cells from non-tg(BALB/c) mice when adoptively trans-
ferred with HA-specific T cells into HA104 mice, and this
activation led to ASC formation and germinal center devel-
opment in the spleens of recipient mice. Third, the neo–
self-HA was able to stimulate autoantibody production in
HA104 mice that had been mated with mice transgenic for
an HA-specific CD41 TCR. Moreover, the autoantibodies
elicited by the neo–self-HA were able to recognize confor-
mation-dependent epitopes on the viral HA molecule.
Based on these lines of evidence, neither antigen inaccessi-
bility nor incorrect folding of the neo–self-HA appears to
be likely explanation for the ability of autoreactive HA-
specific memory response B cells to develop in HA104
mice. There is also evidence that the presence of autoanti-
bodies may mask self-antigens and thus limit the accessibil-
ity of the antigens to self-reactive B cells (18). In the case of
HA-specific antibodies elicited by acute viral immuniza-
tion, masking of HA by these antibodies may indeed allow
for autoreactive B cells that emerge after immunization to
escape tolerance induction mechanisms. However, that we
were able to measure autoantibody production in naive
TS1 3 HA104 mice suggests that masking of autoantigens
by virus-induced antibodies is not necessary for the initia-
tion of autoantibody production to HA.
An alternative explanation for the HA-specific memory
B cell responses that could be induced in HA104 mice is
that B cells are not subjected to negative selection during
memory formation based on the specificity of their BCR
for a self-antigen. Instead, the availability of CD41 T cell
help may play a crucial role in regulating memory autoanti-
body responses. Germinal center reactions depend on cog-
nate interactions between antigen-specific B cells and
CD41 T cells (17), and it has long been recognized that
negative selection of autoreactive CD41 T cells could play
an important role in regulating autoantibody responses (18,
66, 67). Yet, because of the possibility that a foreign anti-
gen (such as a virus) could contain B cell epitopes that
cross-react with self-antigens and provide autoreactive B
cells with help directed to non–self-proteins (20, 21), sev-
eral studies have examined whether B cell intrinsic toler-
ance mechanisms exist to prevent the development of au-
toreactive B cells in germinal centers. Evidence in support
of such mechanisms is mostly indirect, and has been de-
rived from examining the effects of administering high
concentrations of soluble antigens to germinal center B
cells and/or examining how genes that affect lymphocyte
survival influence germinal center reactions (25, 27–31).
We demonstrated here that clonally expanded and somati-
cally mutated B cells using a clonotype (C4) that is typical
of PR8 HA–specific memory B cell responses of influenza
virus–immunized mice BALB/c mice could be isolated
from virus-immunized HA104 mice. Because clonal ex-
pansion and somatic hypermutation occur predominantly
in germinal centers (51, 54), this provides direct evidence
that autoreactive HA-specific B cells had developed in the
germinal center pathway. In addition, two observations
suggest that HA-specific antibodies also underwent affinity
maturation in HA104 mice. First, HA104 and non-
tg(BALB/c) mice contained similar frequencies of HA-spe-
cific ASCs. Second, sera from HA104 and non-tg(BALB/
c) mice contained similar titers of hemagglutination-inhib-
iting antibodies. Unless ASCs from HA104 mice secreted
more antibody per ASC than did those in non-tg(BALB/c)
mice (for which there is no precedence), equivalent serum
titers of HI antibodies suggest that the overall affinity for
the HA of serum from HA104 mice is comparable to that
of non-tg BALB/c mice. Therefore, to the extent that the1772 Maturation of Autoreactive B Cells in the Germinal Center Pathway
levels of hemagglutination-inhibiting antibodies that are
present in the sera of non-tg(BALB/c) mice after secondary
immunization reflect the outcome of somatic mutation and
affinity maturation (38), that HA104 and non-tg(BALB/c)
mice contain both similar frequencies of HA-specific ASCs
and comparable levels of hemagglutination-inhibiting se-
rum antibodies suggests that HA-specific antibodies also
undergo affinity maturation in HA104 mice. In this regard,
it is noteworthy that a low affinity for self-antigens has
been shown previously to allow B cells to evade negative
selection from the primary repertoire (68). As HA104 and
non-tg(BALB/c) mice differ substantially in the frequency
of HA-specific IgG ASCs that are activated after primary
immunization, it is difficult to assess the relative affinity of
their primary serum responses. However, if the HA-spe-
cific B cells that evade negative selection from the primary
B cell repertoire in HA104 mice are of relatively low affin-
ity for the HA, the studies here suggest that affinity matura-
tion allows the secondary response to achieve an affinity
comparable to those in non-tg(BALB/c) mice.
Finally, it is significant to note that the ability of HA-
specific C4 B cells to develop in the germinal center path-
way in HA104 mice was dependent on virus immuniza-
tion. Whereas HA-specific C4 B cell hybridomas isolated 3 d
after secondary immunization in HA104 mice were so-
matically mutated and had undergone H chain class switch-
ing, those isolated 5 d after primary immunization of
HA104 mice expressed unmutated IgM (5). This require-
ment for virus immunization most likely reflects a need for
cognate T cell help to permit activation of these autoreac-
tive B cells. We have demonstrated previously that HA-
specific CD41 T cells are negatively selected in HA104
mice (69), and the idea that negative selection of HA-spe-
cific CD41 T cells plays a role in regulating autoantibody
production in HA104 mice was also inferred from studies
here using TS1 3 HA104 mice. Even though HA-specific
T cells undergo negative selection during their develop-
ment in TS1 3 HA104 mice (58), the rare autoreactive
CD41 T cells that evade deletion by the neo–self-HA are
sufficient to induce autoantibody production in TS1 3
HA104 mice. It will be interesting in future experiments to
determine whether the HA-specific autoantibodies in
TS1  3 HA104 mice derive from B cells that would have
otherwise undergone deletion from the primary repertoire or
from HA-specific B cells that were induced to form mem-
ory by the neo–self-HA in the presence of persistent T cell
help. Regardless of the source of autoantibodies in TS1 3
HA104 mice, it is clear that HA as a neo–self-antigen is ca-
pable of being recognized by HA-specific B cells in vivo.
Moreover, the findings presented here provide evidence
that provision of CD41 T cell help can play a crucial role
in the activation of autoreactive B cells.
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